What Do We (Need to) Know About the Melatonin in Crustaceans?

被引：44

作者：

Sainath, S. B. ^{[1
]}

Swetha, Ch ^{[1
]}

Reddy, P. Sreenivasula ^{[2
]}

机构：

[1] Sri Venkateswara Univ, Dept Biotechnol, Tirupati 517502, Andhra Pradesh, India

[2] Sri Venkateswara Univ, Dept Zool, Tirupati 517502, Andhra Pradesh, India

来源：

JOURNAL OF EXPERIMENTAL ZOOLOGY PART A-ECOLOGICAL AND INTEGRATIVE PHYSIOLOGY | 2013年 / 319卷 / 07期

关键词：

OZIOTELPHUSA-SENEX-SENEX; N-ACETYLTRANSFERASE ACTIVITY; MOLT-INHIBITING HORMONE; CRAB UCA PUGILATOR; FRESH-WATER CRAB; CRAYFISH PROCAMBARUS-CLARKII; TROPICAL LAND CRAB; ROSENBERGII DE-MAN; FIDDLER-CRAB; Y-ORGANS;

D O I：

10.1002/jez.1800

中图分类号：

Q95 [动物学];

学科分类号：

071002 ;

摘要：

Melatonin (N-acetyl-5-methoxy-tryptamine) was first discovered from the bovine pineal gland extract in 1958. Since then, its synthesis, metabolism, physiological, and patho-physiological functions are well studied in vertebrates; there is an increasing recognition of melatonin in invertebrates and especially in crustaceans. The presence of melatonin in crustaceans is now well documented and some functional aspects in the framework of crustacean biology have been demonstrated. This review aims at giving a comprehensive overview of the various physiological events regulated by this pleiotropic hormone. Topics include: glucose homeostasis, regulation of reproduction, molting, limb regeneration, and antioxidant properties. Finally, perspectives on current and possible research are offered. J. Exp. Zool. 319A: 365-377, 2013. (c) 2013 Wiley Periodicals, Inc.

引用

页码：365 / 377

页数：13

共 50 条

[41] BRCA1: What do we know? What do we think we know? What do we really need to know?
Buller, RE
GYNECOLOGIC ONCOLOGY, 2000, 76 (03) : 291 - 293
[42] Mycotoxins and mycotoxicosis in Tunisia: What do we know and what do we need to know?
Bacha, H
Maaroufi, K
Ghedira-Chekir, L
Abid, S
Cherif, A
Achour, A
Creppy, EE
JOURNAL OF TOXICOLOGY-TOXIN REVIEWS, 1999, 18 (3-4): : 245 - 262
[43] The Tradeoffs of Inclusionary Zoning: What Do We Know and What Do We Need to Know?
Mukhija, Vinit
Das, Ashok
Regus, Lara
Tsay, Sara Slovin
PLANNING PRACTICE AND RESEARCH, 2015, 30 (02): : 222 - 235
[44] Translating and Revising for Localisation: What do We Know? What do We Need to Know?
Garcia, Ignacio
PERSPECTIVES-STUDIES IN TRANSLATION THEORY AND PRACTICE, 2008, 16 (1-2): : 49 - 60
[45] INTRATHECAL BACLOFEN AND SPASTICITY - WHAT DO WE KNOW AND WHAT DO WE NEED TO KNOW
ARMSTRONG, RW
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 1992, 34 (08): : 739 - 745
[46] The Community Reinvestment Act: What Do We Know, and What Do We Need to Know?
Goodman, Laurie
Zhu, Jun
Walsh, John
HOUSING POLICY DEBATE, 2020, 30 (01) : 83 - 100
[47] Cerebrovascular diseases in Nigeria: what do we know and what do we need to know?
Ogungbo, BI
Gregson, B
Mendelow, AD
Walker, R
TROPICAL DOCTOR, 2003, 33 (01) : 25 - 30
[48] Measuring inequalities in health: What do we know? What do we need to know?
Costa-Font, Joan
Hernandez-Quevedo, Cristina
HEALTH POLICY, 2012, 106 (02) : 195 - 206
[49] The cost of preventing diabetes - What do we know and what do we need to know?
Teutsch, S
DIABETES CARE, 2003, 26 (01) : 238 - 239
[50] The problem with prostatitis. What do we know? What do we need to know?
Krieger, JN
JOURNAL OF UROLOGY, 2004, 172 (02): : 432 - 433

← 1 2 3 4 5 →